The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort
暂无分享,去创建一个
I. James | F. Christiansen | F. Mastaglia | A. Kermode | W. Carroll | S. Wilton | D. Nolan | A. Castley | W. Qiu | Jingshan Wu | P. Czarniak | M. Garlepp | K. Pham | Yuebei Luo | Petra Czarniak
[1] Isabelle Cournu-Rebeix,et al. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects , 2012, Journal of Medical Genetics.
[2] M. Z. Cader,et al. Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene , 2012, Neurology.
[3] A. López de Munain,et al. HLA-DRB1*15:01 and multiple sclerosis: a female association? , 2012, Multiple sclerosis.
[4] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[5] J. Kira,et al. Interleukin-7 receptor alpha gene polymorphism influences multiple sclerosis risk in Asians , 2011, Neurology.
[6] D. Holtzman,et al. Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.
[7] M. Ban,et al. Evaluation of the established non-MHC multiple sclerosis loci in an Indian population , 2011, Multiple sclerosis.
[8] B. Engelhardt,et al. Differential Roles for Endothelial ICAM-1, ICAM-2, and VCAM-1 in Shear-Resistant T Cell Arrest, Polarization, and Directed Crawling on Blood–Brain Barrier Endothelium , 2010, The Journal of Immunology.
[9] M. Ban,et al. A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis , 2010, European Journal of Human Genetics.
[10] A. Alcina,et al. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility , 2010, Genes and Immunity.
[11] I. James,et al. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia , 2010, Journal of Neuroimmunology.
[12] Ludwig Kappos,et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. , 2010, American journal of human genetics.
[13] A. Janssens,et al. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis , 2009, Journal of Human Genetics.
[14] T. Kilpatrick,et al. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy , 2009, Neurology.
[15] Pablo Moscato,et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.
[16] T. Kilpatrick,et al. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus , 2009, Journal of Neuroimmunology.
[17] Margaret A. Pericak-Vance,et al. The role of the CD58 locus in multiple sclerosis , 2009, Proceedings of the National Academy of Sciences.
[18] James Wason,et al. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor , 2009, European Journal of Human Genetics.
[19] Michael R. Johnson,et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. , 2009, Human molecular genetics.
[20] T. Speed,et al. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians , 2008, Genes and Immunity.
[21] Hanne F. Harbo,et al. Refining genetic associations in multiple sclerosis , 2008, The Lancet Neurology.
[22] Xuebin Liu,et al. Loss of STAT3 in CD4+ T Cells Prevents Development of Experimental Autoimmune Diseases , 2008, The Journal of Immunology.
[23] L. Peltonen,et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations , 2008, Journal of Medical Genetics.
[24] K. Vandenbroeck,et al. IL7RA polymorphisms and susceptibility to multiple sclerosis. , 2008, The New England journal of medicine.
[25] Silke Schmidt,et al. Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis , 2007, Nature Genetics.
[26] H. Harbo,et al. Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis , 2007, Nature Genetics.
[27] S. Gabriel,et al. Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.
[28] J. Haines,et al. APOE epsilon variation in multiple sclerosis susceptibility and disease severity , 2006, Neurology.
[29] F. Svensson,et al. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis , 2005, Genes and Immunity.
[30] E. Génin,et al. Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis , 2003, Genes and Immunity.
[31] J. Ilonen,et al. Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. , 2003, Human immunology.
[32] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[33] G. Le Gros,et al. The role of CTLA‐4 in the regulation of T cell immune responses , 1999, Immunology and cell biology.
[34] K. Selmaj,et al. Multiple sclerosis: The increased frequency of the ICAM‐1 exon 6 gene point mutation genetic type K469 , 1998, Annals of neurology.
[35] G. Stein,et al. Interferon regulatory factors: growth control and histone gene regulation – it’s not just interferon anymore , 1997, Journal of Molecular Medicine.
[36] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.
[37] J. Haines,et al. The expanding genetic overlap between multiple sclerosis and type I diabetes , 2009, Genes and Immunity.
[38] L. Mucke,et al. Apolipoprotein E , 2007, Journal of Molecular Neuroscience.
[39] F. Christiansen,et al. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. , 2001, Tissue antigens.